Effect of insulin analogues on 3t3-l1 adipogenesis and lipolysis

European Journal of Clinical Investigation

Volumn 41, Issue 9, 2011, Pages 979-986

  García Escobar, Eva ^a,b,c   Rodríguez Pacheco, Francisca ^b,d   Haro Mora, Juan J ^a,b,c   Gomez Zumaquero, Juan M ^a,b,c   Rubio Martín, Elehazara ^a,b,c   Gutierrez Repiso, Carolina ^a,b,c   Soriguer, Federico ^a,b,c   Rojo Martínez, Gemma ^a,b,c  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^b Instituto de Salud Carlos III   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Cell differentiation; Insulin analogues; Lipolysis; Preadipocyte

Indexed keywords

INSULIN; INSULIN ASPART; INSULIN DETEMIR; INSULIN GLARGINE; INSULIN LISPRO; INSULIN RECEPTOR; ISOPHANE INSULIN; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN; RECOMBINANT HUMAN INSULIN; SCD 1 PROTEIN; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; UNCLASSIFIED DRUG;

ADIPOCYTE; ADIPOGENESIS; ARTICLE; CELL DIFFERENTIATION; CELL STRUCTURE; CONTROLLED STUDY; DRUG EFFECT; GENE EXPRESSION; IN VITRO STUDY; LIPOLYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

3T3-L1 CELLS; ADIPOCYTES; ADIPOGENESIS; ANALYSIS OF VARIANCE; ANIMALS; GENE EXPRESSION REGULATION; HUMANS; INSULIN; LIPOLYSIS; MICE;

EID: 79961011969     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2011.02492.x     Document Type: Article

References (40)

1. Sharma MD, Garber AJ, Farmer JA. Role of insulin signaling in maintaining energy homeostasis. Endocr Pract 2008;14:373-80.
2. Russell-Jones D, Khan R. Insulin-associated weight gain in diabetes - causes, effects and coping strategies. Diabetes Obes Metab 2007;9:799-812.
3. Duran C, Tuncel E, Ersoy C, Ercan I, Selimoglu H, Kiyici S et al. The investigation of the efficacy of insulin glargine on glycemic control when combined with either repaglinide or acarbose in obese type 2 diabetic patients. J Endocrinol Invest 2009;32:69-73.
4. Korytkowski MT, Salata RJ, Koerbel GL, Selzer F, Karslioglu E, Idriss AM et al. Insulin therapy and glycemic control in hospitalized patients with diabetes during enteral nutrition therapy: a randomized controlled clinical trial. Diabetes Care 2009;32:594-6.
5. Boyle ME. Optimizing the treatment of type 2 diabetes using current and future insulin technologies. Medsurg Nurs 2008;17:383-90.
6. Muretta JM, Mastick CC. How insulin regulates glucose transport in adipocytes. Vitam Horm 2009;80:245-86.
7. Chang L, Chiang SH, Saltiel AR. Insulin signaling and the regulation of glucose transport. Mol Med 2004;10:65-71.
8. Yokoo H, Nemoto T, Yanagita T, Satoh S, Yoshikawa N, Maruta T et al. Glycogen synthase kinase-3beta: homologous regulation of cell surface insulin receptor level via controlling insulin receptor mRNA stability in adrenal chromaffin cells. J Neurochem 2007;103:1883-96.
9. Hojlund K, Poulsen M, Staehr P, Brusgaard K, Beck-Nielsen H. Effect of insulin on protein phosphatase 2A expression in muscle in type 2 diabetes. Eur J Clin Invest 2002;32:918-23.
10. Arufe MC, Lu M, Lin RY. Differentiation of murine embryonic stem cells to thyrocytes requires insulin and insulin-like growth factor-1. Biochem Biophys Res Commun 2009;381:264-70.
11. Sanders EJ, Harvey S. Peptide hormones as developmental growth and differentiation factors. Dev Dyn 2008;237:1537-52.
12. Yu B, Zhang Z, Deng X, Xu X, Feng C, Li Y et al. Involvement of insulin in early development of mouse one-cell stage embryos. Sci China C Life Sci 2008;51:767-73.
13. Laville M, Andreelli F. Mechanisms for weight gain during blood glucose normalization. Diabetes Metab 2000;26(Suppl. 3):42-5.
14. Hennige AM, Sartorius T, Tschritter O, Preissl H, Fritsche A, Ruth P et al. Tissue selectivity of insulin detemir action in vivo. Diabetologia 2006;49:1274-82.
15. Zib I, Raskin P. Novel insulin analogues and its mitogenic potential. Diabetes Obes Metab 2006;8:611-20.
16. Mudaliar S, Mohideen P, Deutsch R, Ciaraldi TP, Armstrong D, Kim B et al. Intravenous glargine and regular insulin have similar effects on endogenous glucose output and peripheral activation/deactivation kinetic profiles. Diabetes Care 2002;25:1597-602.
17. Plank J, Bodenlenz M, Sinner F, Magnes C, Gorzer E, Regittnig W et al. A double-blind, randomized, dose-response study investigating the pharmacodynamic and pharmacokinetic properties of the long-acting insulin analog detemir. Diabetes Care 2005;28:1107-12.
18. Wada T, Azegami M, Sugiyama M, Tsuneki H, Sasaoka T. Characteristics of signalling properties mediated by long-acting insulin analogue glargine and detemir in target cells of insulin. Diabetes Res Clin Pract 2008;81:269-77.
19. Fawcett J, Tsui BT, Kruer MC, Duckworth WC. Reduced action of insulin glargine on protein and lipid metabolism: possible relationship to cellular hormone metabolism. Metabolism 2004;53:1037-44.
20. Somwar R, Sweeney G, Ramlal T, Klip A. Stimulation of glucose and amino acid transport and activation of the insulin signaling pathways by insulin lispro in L6 skeletal muscle cells. Clin Ther 1998;20:125-40.
21. Reed BC, Lane MD. Insulin receptor synthesis and turnover in differentiating 3T3-L1 preadipocytes. Proc Natl Acad Sci USA 1980;77:285-9.
22. Wu Z, Xie Y, Morrison RF, Bucher NL, Farmer SR. PPARgamma induces the insulin-dependent glucose transporter GLUT4 in the absence of C/EBPalpha during the conversion of 3T3 fibroblasts into adipocytes. J Clin Invest 1998;101:22-32.
23. Watkins PA, Moss J, Pekala PH, Lane MD. Effect of differentiation on the adenylate cyclase system of 3T3-C2 and 3T3-L1 cells. Determination of choleragen substrates in differentiating 3T3-L1 and nondifferentiating 3T3-C2 cells. J Biol Chem 1982;257:14719-22.
24. Rosen ED, MacDougald OA. Adipocyte differentiation from the inside out. Nat Rev Mol Cell Biol 2006;7:885-96.
25. Bohm A, Staiger H, Hennige AM, Haas C, Machicao F, Haring HU. Effect of insulin detemir, compared to human insulin, on 3T3-L1 adipogenesis. Regul Pept 2008;151:160-3.
26. Soliman MM, El-Senosi YA, Salem MM, Abdel Hamid OM, Kazuhiro K. Role of protease inhibitors and acylation stimulating protein in the adipogenesis in 3T3-L1 cells. J Vet Sci 2009;10:197-201.
27. Li YX, Meng JX, Cai XZ, Li DF, Rong KB, Jiang WL et al. Induced differentiation and signaling factor PTEN expression of 3T3-L1 adipocytes. Nan Fang Yi Ke Da Xue Xue Bao 2007;27:259-63.
28. Wade FM, Wakade C, Mahesh VB, Brann DW. Differential expression of the peripheral benzodiazepine receptor and gremlin during adipogenesis. Obes Res 2005;13:818-22.
29. Granlund L, Pedersen JI, Nebb HI. Impaired lipid accumulation by trans10, cis12 CLA during adipocyte differentiation is dependent on timing and length of treatment. Biochim Biophys Acta 2005;1687:11-22.
30. Kurtzhals P, Schaffer L, Sorensen A, Kristensen C, Jonassen I, Schmid C et al. Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use. Diabetes 2000;49:999-1005.
31. Davies MJ, Derezinski T, Pedersen CB, Clauson P. Reduced weight gain with insulin detemir compared to NPH insulin is not explained by a reduction in hypoglycemia. Diabetes Technol Ther 2008;10:273-7.
32. Large V, Peroni O, Letexier D, Ray H, Beylot M. Metabolism of lipids in human white adipocyte. Diabetes Metab 2004;30:294-309.
33. Holm C. Molecular mechanisms regulating hormone-sensitive lipase and lipolysis. Biochem Soc Trans 2003;31:1120-4.
34. Soriguer F, Moreno F, Rojo-Martinez G, Garcia-Fuentes E, Tinahones F, Gomez-Zumaquero JM et al. Monounsaturated n-9 fatty acids and adipocyte lipolysis in rats. Br J Nutr 2003;90:1015-22.
35. Ciaraldi TP, Carter L, Seipke G, Mudaliar S, Henry RR. Effects of the long-acting insulin analog insulin glargine on cultured human skeletal muscle cells: comparisons to insulin and IGF-I. J Clin Endocrinol Metab 2001;86:5838-47.
36. Kersten S. Mechanisms of nutritional and hormonal regulation of lipogenesis. EMBO Rep 2001;2:282-6.
37. Yellaturu CR, Deng X, Park EA, Raghow R, Elam MB. Insulin enhances the biogenesis of nuclear sterol regulatory element-binding protein (SREBP)-1c by posttranscriptional down-regulation of Insig-2A and its dissociation from SREBP cleavage-activating protein (SCAP)·SREBP-1c complex. J Biol Chem 2009;284:31726-34.
38. Weiner FR, Smith PJ, Wertheimer S, Rubin CS. Regulation of gene expression by insulin and tumor necrosis factor alpha in 3T3-L1 cells. Modulation of the transcription of genes encoding acyl-CoA synthetase and stearoyl-CoA desaturase-1. J Biol Chem 1991;266:23525-8.
39. Le Lay S, Lefrere I, Trautwein C, Dugail I, Krief S. Insulin and sterol-regulatory element-binding protein-1c (SREBP-1C) regulation of gene expression in 3T3-L1 adipocytes. Identification of CCAAT/enhancer-binding protein beta as an SREBP-1C target. J Biol Chem 2002;277:35625-34.
40. Kim YC, Ntambi JM. Regulation of stearoyl-CoA desaturase genes: role in cellular metabolism and preadipocyte differentiation. Biochem Biophys Res Commun 1999;266:1-4.